Skip to main content
. 2018 Jan 5;13(1):e0188983. doi: 10.1371/journal.pone.0188983

Table 2. Assessment of interaction between Ki67 indices and clinico-pathological variables.

RS Ki67 Index
(Whole-slide)
P Value Ki67 Index
(Hot-spot)
P Value
Low 6.86 Int. vs Low = 0.012 15.84 Int. vs Low = 0.005
Intermediate 8.33 High vs Low < 0.001 19.21 High vs Low < 0.001
High 20.21 High vs Int. < 0.001 43.66 High vs Int. < 0.001
Tumor Grade
1 8.15 2 vs 1 = 0.297 16.49 2 vs 1 = 0.704
2 6.53 3 vs 1 < 0.001 16.08 3 vs 1 < 0.001
3 7.46 3 vs 2 < 0.001 33.88 3 vs 2 < 0.001
ER Score
ER<5 16.96 0.004 36.98 0.002
ER = 5 7.05 16.46
PgR Score
PgR<5 8.98 0.012 20.63 0.008
PgR = 5 6.66 15.27
Nuclear Grade
1 7.11 2 vs 1 = 0.555 17.10 2 vs 1 = 0.232
2 6.85 3 vs 1 = 0.046 16.06 3 vs 1 = 0.129
3 10.5 3 vs 2 < 0.001 23.83 3 vs 2 < 0.001
Mitotic Score
1 6.63 2 vs 1 < 0.001 15.68 2 vs 1 < 0.001
2 11.95 3 vs 1 < 0.001 25.99 3 vs 1 < 0.001
3 17.54 3 vs 2 = 0.005 35.93 3 vs 2 = 0.008

RS, recurrence score; Int, intermediate-risk group; ER, estrogen receptor; PgR, progesterone receptor.